Journal Title
Cancer Medicine

CANCER MED-US

ISSN / eISSN
2045-7634 / 2045-7634
Aims and Scope
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.

Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.

Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.


Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
Subject Area

ONCOLOGY

CiteScore
5.50 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Radiology, Nuclear Medicine and Imaging Q1 #81/333
Medicine - Oncology Q2 #145/404
Medicine - Cancer Research Q3 #120/230
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
ONCOLOGY Q2
H-index
34
Country/Area of Publication
UNITED STATES
Publisher
John Wiley and Sons Ltd
Annual Article Volume
1215
Open Access
YES
Contact
111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
What you have is nothing. I submitted in March, and it has been 10 months already. It is still under review. I have urged them countless times, but they just ignore me. Well, I don't have the time to submit to other magazines either. Let's see who can outlast whom. I hope to challenge the conventional understanding.
2021-01-29
Submitted at the end of the year, pending editor for two months, and then pending decision for another month. The reviewers didn't provide any feedback, and it took three months before they finally informed me of the rejection.
2022-03-14

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now